Literature DB >> 6825237

Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure.

W H Fennell, A A Taylor, J B Young, T A Brandon, J Z Ginos, L I Goldberg, J R Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6825237     DOI： 10.1161/01.cir.67.4.829

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Authors:  D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

2.  A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2-receptor agonist.

Authors:  G Acton; C Broom
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 3.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

4.  Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

5.  The effects of dopexamine on the cardiovascular system of the dog.

Authors:  R A Brown; J B Farmer; J C Hall; R G Humphries; S E O'Connor; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

Review 6.  Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020.

Authors:  Mara Bagardi; Viola Zamboni; Chiara Locatelli; Alberto Galizzi; Sara Ghilardi; Paola G Brambilla
Journal:  Animals (Basel)       Date:  2022-01-16       Impact factor: 2.752
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.